Group One Trading’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-21,200
| Closed | -$815K | – | 8618 |
|
|
2023
Q2 | $815K | Buy |
21,200
+20,000
| +1,667% | +$514K | ﹤0.01% | 2545 |
|
|
2023
Q1 | $27.8K | Buy |
1,200
+1,000
| +500% | +$23.8K | ﹤0.01% | 5300 |
|
|
2022
Q4 | $5.24K | Sell |
200
-2,100
| -91% | -$46.5K | ﹤0.01% | 6329 |
|
|
2022
Q3 | $45K | Buy |
2,300
+300
| +15% | +$6.02K | ﹤0.01% | 5494 |
|
|
2022
Q2 | $35K | Buy |
+2,000
| New | +$31.4K | ﹤0.01% | 5872 |
|
|
2022
Q1 | – | Sell |
-200
| Closed | -$3K | – | 8984 |
|
|
2021
Q4 | $3K | Buy |
+200
| New | +$2.85K | ﹤0.01% | 7836 |
|
|
2020
Q3 | – | Sell |
-7,040
| Closed | -$81K | – | 6692 |
|
|
2020
Q2 | $81K | Buy |
7,040
+2,720
| +63% | +$37.5K | ﹤0.01% | 4066 |
|
|
2020
Q1 | $59K | Buy |
4,320
+380
| +10% | +$4.49K | ﹤0.01% | 3609 |
|
|
2019
Q4 | $23K | Buy |
+3,940
| New | +$21.4K | ﹤0.01% | 4327 |
|
|
2019
Q2 | – | Sell |
-1,520
| Closed | -$30K | – | 5533 |
|
|
2019
Q1 | $30K | Sell |
1,520
-880
| -37% | -$15.3K | ﹤0.01% | 3848 |
|
|
2018
Q4 | $32K | Buy |
2,400
+600
| +33% | +$12K | ﹤0.01% | 3783 |
|
|
2018
Q3 | $66K | Sell |
1,800
-2,660
| -60% | -$85.4K | ﹤0.01% | 3803 |
|
|
2018
Q2 | $156K | Hold |
4,460
| – | – | ﹤0.01% | 3246 |
|
|
2018
Q1 | $207K | Buy |
4,460
+3,160
| +243% | +$116K | ﹤0.01% | 2775 |
|
|
2017
Q4 | $49K | Buy |
+1,300
| New | +$56.8K | ﹤0.01% | 3745 |
|
|
2017
Q1 | – | Sell |
-2,040
| Closed | -$116K | – | 5119 |
|
|
2016
Q4 | $116K | Buy |
2,040
+1,760
| +629% | +$106K | ﹤0.01% | 2757 |
|
|
2016
Q3 | $17K | Sell |
280
-540
| -66% | -$38.2K | ﹤0.01% | 3860 |
|
|
2016
Q2 | $46K | Buy |
820
+140
| +21% | +$8.51K | ﹤0.01% | 3356 |
|
|
2016
Q1 | $44K | Buy |
680
+620
| +1,033% | +$50.1K | ﹤0.01% | 3330 |
|
|
2015
Q4 | $8K | Sell |
60
-160
| -73% | -$21.7K | ﹤0.01% | 4266 |
|
|
2015
Q3 | $21K | Sell |
220
-60
| -21% | -$7.14K | ﹤0.01% | 4023 |
|
|
2015
Q2 | $42K | Buy |
+280
| New | +$46.2K | ﹤0.01% | 3656 |
|
Group One Trading's KDNY Position: Q4 2022 in Review
Group One Trading sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q4 2022, closing a stake of 2,600 shares — an estimated $57.6K sold.
Group One Trading first reported a position in KDNY in Q3 2015 and held it in 15 quarters. The position peaked at $262K in Q1 2016. 155 funds tracked by Wall St. Rank hold KDNY as of Q4 2022.
- Group One Trading reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
- Group One Trading sold 2,600 Chinook Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $57.6K.
- Group One Trading first reported a position in Chinook Therapeutics, Inc. Common Stock in Q3 2015 and held it in 15 quarters.
- Group One Trading's Chinook Therapeutics, Inc. Common Stock position peaked at $262K in Q1 2016.
- 155 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q4 2022.
Based on Group One Trading's 13F filing for Q4 2022, filed 9 Feb 2023.